BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fantini MC, Guadagni I. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies. Dig Liver Dis 2021;53:558-65. [PMID: 33541800 DOI: 10.1016/j.dld.2021.01.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Nagao-Kitamoto H, Kitamoto S, Kamada N. Inflammatory bowel disease and carcinogenesis. Cancer Metastasis Rev 2022. [PMID: 35416564 DOI: 10.1007/s10555-022-10028-4] [Reference Citation Analysis]
2 Guo J, Liao M, Wang J. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155. Cell Commun Signal 2021;19:90. [PMID: 34479599 DOI: 10.1186/s12964-021-00771-6] [Reference Citation Analysis]
3 Frigerio S, Lartey DA, D'Haens GR, Grootjans J. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. Int J Mol Sci 2021;22:12739. [PMID: 34884543 DOI: 10.3390/ijms222312739] [Reference Citation Analysis]
4 Sava A, Buron F, Routier S, Panainte A, Bibire N, Constantin SM, Lupașcu FG, Focșa AV, Profire L. Design, Synthesis, In Silico and In Vitro Studies for New Nitric Oxide-Releasing Indomethacin Derivatives with 1,3,4-oxadiazole-2-thiol Scaffold. Int J Mol Sci 2021;22:7079. [PMID: 34209248 DOI: 10.3390/ijms22137079] [Reference Citation Analysis]
5 Sava A, Buron F, Routier S, Panainte A, Bibire N, Profire L. New nitric oxide-releasing indomethacin derivatives with 1,3-thiazolidine-4-one scaffold: Design, synthesis, in silico and in vitro studies. Biomed Pharmacother 2021;139:111678. [PMID: 33964802 DOI: 10.1016/j.biopha.2021.111678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zeng S, Chen L, Sun Q, Zhao H, Yang H, Ren S, Liu M, Meng X, Xu H. Scutellarin ameliorates colitis-associated colorectal cancer by suppressing Wnt/β-catenin signaling cascade. Eur J Pharmacol 2021;906:174253. [PMID: 34118224 DOI: 10.1016/j.ejphar.2021.174253] [Reference Citation Analysis]
7 Kotelevets L, Chastre E. A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer. Cancers (Basel) 2021;13:4264. [PMID: 34503076 DOI: 10.3390/cancers13174264] [Reference Citation Analysis]
8 Leite CDS, Bonafé GA, Carvalho Santos J, Martinez CAR, Ortega MM, Ribeiro ML. The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders. Int J Mol Sci 2022;23:4121. [PMID: 35456938 DOI: 10.3390/ijms23084121] [Reference Citation Analysis]
9 Bandaru SS, Boyilla R, Merchant N, Nagaraju GP, El-rayes B. Targeting T regulatory cells: their role in colorectal carcinoma progression and current clinical trials. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106197] [Reference Citation Analysis]
10 Wang D, Xie B. Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer. Eur J Med Res 2022;27:91. [PMID: 35698180 DOI: 10.1186/s40001-022-00720-0] [Reference Citation Analysis]
11 Palko-Łabuz A, Maksymowicz J, Sobieszczańska B, Wikiera A, Skonieczna M, Wesołowska O, Środa-Pomianek K. Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity. Cancers (Basel) 2021;13:2952. [PMID: 34204704 DOI: 10.3390/cancers13122952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]